Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BRAINBox Solutions has developed the first comprehensive AI-enabled multi-modality diagnostic and prognostic tool for mild traumatic brain injury. The system combines proprietary blood biomarker panels with digital neurocognitive assessments to generate an objective score for diagnosis within up to 96 hours of injury and predicts likelihood of post-injury symptoms at both one month and three months. The pivotal HeadSMART II study has enrolled over 2200 subjects across multiple sites internationally. Early data support high accuracy in both diagnosis and prognosis compared to current standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BRAINBox Solutions.